Sino Biopharmaceutical Limited (HKG:1177)
Hong Kong · Delayed Price · Currency is HKD 5.95
-0.05 (-0.83%)
Apr 20, 2026, 4:08 PM HKT
Sino Biopharmaceutical Market Cap
Sino Biopharmaceutical has a market cap or net worth of 106.31 billion as of April 20, 2026. Its market cap has increased by 64.69% in one year.
Market Cap
106.31B
Enterprise Value
111.81B
Revenue
35.43B
Ranking
n/a
PE Ratio
41.19
Stock Price
5.95
Market Cap Chart
Since September 29, 2000, Sino Biopharmaceutical's market cap has increased from 329.97M to 106.31B, an increase of 32,118.69%. That is a compound annual growth rate of 25.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 106.31B | -3.77% |
| Dec 31, 2025 | 110.48B | 89.64% |
| Dec 31, 2024 | 58.26B | -8.75% |
| Dec 29, 2023 | 63.85B | -24.41% |
| Dec 30, 2022 | 84.46B | -17.53% |
| Dec 31, 2021 | 102.41B | -27.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 278.28B |
| Innovent Biologics | 158.77B |
| WuXi Biologics | 147.80B |
| Akeso | 139.09B |
| Sichuan Kelun-Biotech Biopharmaceutical | 121.26B |
| RemeGen | 85.82B |
| 3SBio | 63.09B |
| Shanghai Junshi Biosciences | 47.13B |